A recent study reported that peripheral irisin injection in transgenic tau mice can reduce tau phosphorylation and mitigate neuroinflammation, although its potential to reverse tau-induced cognitive deficits remains uncertain [19]. This evidence concerns the gene MAPT and Cognitive impairment.